Abstract: Rutheniump olypyridyl complexes have received widespreada ttention as potential chemotherapeutics in photodynamic therapy (PDT) and in photochemotherapy (PACT). Here, we investigate as eries of sixteen ruthenium polypyridylc omplexes with general formula [Ru(tpy)
Introduction
Ruthenium based anti-cancer compoundsh aveb een investigated for several decades [1] as potential alternatives to the clinically approved cisplatin. Cisplatin is associatedw ith serious side effects such as renal toxicity, neurotoxicity,a nd hearing loss. [2] The most thoroughly investigated ruthenium-based anti-cancer agents, NAMI-Aa nd KP1019, both reached phase II clinicaltrials before being abandoned.
[3] More recently,t he tunable photophysical properties of ruthenium(II) polypyridyl complexes have been used to develop compounds combating bacterialr esistance to antibiotics, [4] or new photosensitizersf or photodynamic therapy as an alternative to, for example, Photofrin.
[5] Recently,t he group of McFarland have made ag reat step forward in this field, by entering phase Ic linicalt rials with aR u II -thiophene-polypyridyl-based photosensitizer,T LD1433. [6] Simultaneously,ag reat interest has been shown in the development of sterically strained ruthenium(II) complexes for the light-induced delivery of cytotoxic cargo. [7] This last approach is often referred to as photo-activated chemotherapy (PACT). [3b, 8] The proof-of-concept for ruthenium-based PACT was first demonstrated by Etchenique's group, who demonstratedt he photorelease of the potassium channel blocker4 -aminopyridine (4AP) from [Ru(bpy) 2 (4AP) 2 ] 2 + upon visible light irradiation. [9] Many other examples of ruthenium complexes used as photosensitive agents releasing anticancer molecules have been developed by the group of Turro, [10] Gasser, [11] Glazer, [12] Kodanko, [13] and Bonnet. [14] Following up on our initial work using thioether monodentate ligands to cage cytotoxic aqua ruthenium complexes, [14b, 15] we report here as eries of related chloride complexes [1a] Cl- [8a] Cl having the generalf ormula [Ru(tpy)(NÀN)(Cl)]Cl with NÀN = bpy (2,2'-bipyridine), phen (1,10-phenanthroline), dpq (pyrazino [2,3- On the one hand, [Ru(tpy)(bpy)(Cl)]Cl is knownt ob ep oorly cytotoxic to cancer cells.
[ 
Results

Synthesis
Chloride complexes [1a] Cl, [16] [2a]Cl, [17] [4a]Cl, [18] [5a]Cl, [14b] [7a]Cl, [19] [8a]Cl, [20] and the ligand 2-(2-(2-(methylthio)ethoxy)-ethoxy)ethyl-b-d-glucopyranoside (R) [14b] were synthesized as reportedp reviously.C omplexes [3a] [21] all thioether complexes showed an upfield shift of the methylsulfide group to about1.5 ppm in the 1 HNMR spectra,c onfirming coordination of the thioether donora tom to the ruthenium center.A ll new compounds were characterized using NMR spectroscopy,thin layer chromatography,e lectronic absorption spectroscopy,h igh-resolution mass spectrometry,and elemental analysis. (Figure 2 ). The three crystal structures showedt he expected distorted octahedral geometry,w ith ar educed (< 1808)N -Ru-N angle for the coordinated terpyridine ligand (N1-Ru1-N3, 159.11-159.408,T able 1). The bidentate ligandsd pq, dppz and dppn are all bound perpendicular to tpy,w ith aN 4-Ru1-N5 bite angle of 79.26-80.28 (Table 1 ). The Ru1ÀCl1 bond lengths were found to be similar with valuesr anging from 2.4015 to 2.4165 which are very close to reported values for relatedc omplexes.
Crystal structures
[22] Selected bond lengths and angles are given in Ta ble 1.
Photophysicalp roperties of the [Ru(tpy)(NN)(L)]
n + + complexes
The photophysical properties of chloride complexes [1a] Cl- [8a] Cl were first investigated in acetonitrile, in which the com- n + ,N ÀN = bpy,phen, dpq, dppz, dppn, pmip, pymi or azpy.L= Cl
plexes are all soluble and do not hydrolyze. The ligand photosubstitution was characterizedb yc lear isosbestic points in the UV/Vis spectra (450 to 476 nm depending on the compound), as shown in Figure 3 . For each of these reactions ab athochromic shift of the 1 MLCT band was observed, which is consistent with earlier reports on the formation of monoaqua-ruthenium complexes in aqueous solution. [15a] Most complexes have ap hotosubstitution quantumy ield (F 450 )o f 0.5-2 percent, leadingt op hotosubstitution reactivities (x = F 450 < mx > e 450, in which e 450 is the molar absorption at 450 nm) on the order of ten to hundreds (x = 11-256). Changing the bidentate ligand has thus as ignificant influence on the photosubstitution rates. Interestingly,t he dppz complex [4b] 2 + has the highest photosubstitutionq uantum yield of the series, which is also about 20-foldh igher( F 450 = 0.020) than that of the structurally similard ppn analogue [5b] 2 + ,w hich showed the lowest F 450 (0.00095).
[ [14b] Cells were seeded at t = 0, treated after 24 hw ith ac oncentration gradient of each ruthenium complex, irradiated or maintained in the dark after replacing the media, and further incubated in the dark for 48 h. At t = 96 hc ell viability was determined using the sulforhodamine B( SRB) assay. [24] The effective concentrations( EC 50 ), defined as the concentration at which a5 0% survival rate on cell viability is observed, are reportedi nT able 3. Mostc hloride complexes were found to be non-cytotoxic, with the exception of [8a] Cl that was found moderately cytotoxic (EC 50 = 28 mm) againstt he MCF-7 cell line, in agreement with the value reported by Reedijk and co-workers. [25] The values for[ 4a]Cl (59 mm and 34 mm against A549 and MCF-7, respectively) were found similar to that observed for [Ru(bpy)(dppz) 2 ] 2 + analogues reported by the group of Schatzschneider. [26] Based on their results, it was expected that the structurally similar but more lipophilic dppn complex [5a]Cl would be cytotoxic, but no significant toxicity was observedf or this complex. On the other hand, its EC 50 could not be clearly determined due to the poor solubility of this complexi nc ell culture medium.
[14b] Interestingly however,[ 5a]Cl was to be found cytotoxic upon blue light irradiation, with EC 50 values of 9.7 and 3.2 mm for A549 and MCF-7 cells, respectively,c orresponding to photoindexes (PI) of more than 2.6 and 7.9, respectively.T his result is unexpected, because the 1 O 2 quantum yield of [5a]Cl (0.023) is much lower than that of its glycoconjugated analogue [5b](PF 6 ) 2 (0.71). Ap ossible explanation would be the partial conversion,a fter uptake, of the chloride complex to its aquated counterpart [Ru(tpy)(dppn)(H 2 O)] 2 + (Figure 4a ), which has been demonstrated to be ag ood [14b] An alternative explanation would be that ad ifferent type of PDT is occurring, such as PDT type I, which is dependentu pon the formation of radical species withouti ntervention of molecular oxygen. [27] Further studies would be neededt oc onclude on the biological mechanism of the photocytoxicity of [5a]Cl. None of the glycoconjugated complexes were foundt ob e photocytotoxic except [5b](PF 6 ) 2 ,w hich was recently reported to enter passively into the cells and to destroy mitochondrial DNA by singlet oxygen generation.
[14b] In our standard treatment protocol, media is replaced before light irradiation. In such conditions, photocytotoxicity can solely rely on the molecules that have been taken up by the cells during incubation, which may be ap roblem for highly hydrophilic glucose-conjugates such as [1b](PF 6 ) 2 -[8b](PF 6 ) 2 (see below).
For compound [4b](PF 6 ) 2 ,a na djustment of the protocol, consisting in irradiating the cells without media refreshing, led to am odest but clearly improved PI (2.4 and 2.6 for MCF-7 and A549, respectively). With such ap rotocol the full dose of compound added to each wellr emains present during and after irradiation,a nd most importantly activation may occur outside the cell, and be followed by cellular uptake of the activated photoproduct.F or [4b](PF 6 ) 2 ,t he observed phototoxicity might thus be explained by the formation of the aquated species [Ru(tpy)(dppz)(H 2 O)]
2 + outsidet he cell, followed by in situ conversion to the chloride species[ 4a]Cl due to the high chloride content in media (> 100 mm), followed by cellular uptake (Figure 4b ). This interpretationi ss upported by the EC 50 values found for[ 4a]Cl, which were not impressive but couldc learly be measured (59 and 34 mm for A549 and MCF-7 respectively). Not refreshing the media before light activationd id not lead to enhancedt oxicity for [1b](PF 6 ) 2 -[3b](PF 6 ) 2 and for [6b](PF 6 ) 2 -[7b](PF 6 ) 2 ,s howingt hat keeping high concentrations of the prodrug during and after light irradiation does not necessarily lead to enhanced phototoxicity.O verall,t hese results demonstrate that [4b](PF 6 ) 2 is am oderately effective PACT agent, [3b] whereas the dppn analogues [5a]Cl and [5b](PF 6 ) 2 are catalytic PDT sensitizers, which can be activated using al ow dose of blue light. They also demonstrate that apparently minor differences in the treatment protocol of lightactivated drugs may lead to very different interpretation of the cytotoxicity of light-activated compounds.
Log P o/w and uptake
To acquire more insight on the effecto fg lycoconjugation on the solubility,c ellular uptake, and toxicity of these complexes, the water-octanol partitionc oefficients (log P o/w )w ere determined for all complexes according to reporteds tandards (Figure 5b) . [28] As shown in Figure 5b To check whether the low toxicity of the thioether-glucose conjugates was not simply due to al ow uptake, cellular uptake was studied for all sixteen complexes in A549 cells at a concentration of 25 mm,u sing an incubation time of 24 ha nd measuring intracellular ruthenium concentrationsb yI CP-MS. Although no general correlation could be found between the log P o/w values for these complexes and their cellular uptake, very strong differences in metal uptake were observedd epending on the ligandsa nd counterions (Figure 5a) 2 ,w hich have comparable log P o/w values. These results may not necessarily represent the conditions experienced by these compounds at the cell membrane, for which it is more likelyt hat the lipophilic PF 6 À counterions are already exchanged for the more abundanta nd more water soluble chloride or phosphate anions in the buffer,c anceling the effect of the PF 6 À anion on lipophilicity. 2 + )n ot enough reactive oxygen speciesc ould be generated to kill the cells. This example demonstrates that the potentialo f [4b](PF 6 ) 2 as aP ACT agent is determined by the treatment protocol, whichs hould be taken into account in further PACT studies. Furthermore, this complex has been shown to act has aD NA light-switch in the presence of DNA, which might be useful fortheranostic applications. [29] 
Conclusion
Overall eight chloride terpyridine complexes [1a] Cl- [8a] Cl with eight different bidendate spectator chelating ligands, and their eight thioether-glucosec onjugates,w eres ynthesized to compare the corresponding photophysical properties,p hotoreactivity,w ater solubility,c ellular uptake, and phototoxicity. Dependingo nt he bidentate ligand,t hesec omplexes can be considered either for photocaging, or for PACT and/or PDT. Compound [8a] Cl is not suitable for photocaging or phototherapy because the azo group of the azpy spectatorl igand stabilizes the 3 MLCT states too much and prevents thermal population of the 3 MC state, thereby quenching photosubstitution. Singlet oxygen generation was also fully quenched in [8a] Cl and [8b](PF 6 ) 2 ,e mphasizing the poor photosensitizing properties of this compound. The five complexes [1a] Cl- [3a] Cl, [6a]Cl, and [7a]Cl, are non-toxic, ando nce substituted by thioethers, they form complexes with similarp hotosubstitution quantum yields (F 450 % 0.01) and low 1 O 2 production quantum yields (F D < 0.10). As ac onsequence, they are excellent candidates for the photocaging of thioether-based biologically active compounds,s uch as the antibiotics amoxicillin and clindamycin. The exceptionally high cellular uptake measured for [6a]Cl is worth noticing( 5220 AE 737 ng Ru per million cells), considering that this compound did not show any measurable cytotoxicity at concentrations lower than 25 mm.I tc an even turn highly hydrophilic compounds such as Rinto species such as [6b](PF 6 ) 2 that are still lipophilic enough to enter into cancer cells. Finally,[ 4a]Cl and[ 5a]Cl shows imilarl ipophilicity compared to [6a]Cl and comparably high cellularu ptake, but they also showed somet oxicity both in the dark and after light activation.T hey are therefore less interesting as PACT carriers andi nstead have better potentiala sae ither ac ytotoxic PACT agent or for PDT,a sw eh ave recently demonstrated for [5b](PF 6 ) 2.
[14b] Overall,t his work demonstrates that complexes based upon the [Ru(tpy)(NN)(R)] n + scaffold are good photocaging agentsb ut poorly (photo)cytotoxic unless DNA intercalators such as dppz and dppn are chosen as ab identate ligand, in which case they could serve as phototoxic agents.
